Your browser doesn't support javascript.
loading
Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle.
Vorgerd, M; Zange, J.
Afiliação
  • Vorgerd M; Department of Neurology, Neuromuscular Centre Ruhrgebiet, Ruhr-University Bochum, Germany. matthias.Vorgerd@rurh-uni-bochum.de
Acta Myol ; 26(1): 61-3, 2007 Jul.
Article em En | MEDLINE | ID: mdl-17915573
ABSTRACT
McArdle's disease is caused by genetic defects of the muscle-specific isozyme of glycogen phosphorylase, which block ATP formation from glycogen in skeletal muscle. Creatine supplementation and ketogenic diet have been tested as potential supplements for muscle energy metabolism which may improve muscle symptomatic. Outcome measures were clinical scores describing muscle symptomatic and parameters derived from 31P-MRS examinations on working muscle. In two placebo controlled cross-over studies low dose creatine showed beneficial effects on muscle symptoms and performance whereas high dose creatine distinctly worsened muscle symptomatic in patients. In both studies, however, the absence of an elevation in phosphocreatine indicated the absence of a creatine uptake by the muscle fibre. The effects of creatine on muscle symptomatic may be independent from energy metabolism in muscle. In a case study, ketogenic diet improved muscle symptomatic and performance. However, these effects again did not result in 31P-MRS visible changes in muscle energy metabolism.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Depósito de Glicogênio Tipo V / Músculo Esquelético / Creatina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2007 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Depósito de Glicogênio Tipo V / Músculo Esquelético / Creatina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2007 Tipo de documento: Article